<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">ARYA Atheroscler</journal-id><journal-id journal-id-type="iso-abbrev">ARYA Atheroscler</journal-id><journal-id journal-id-type="publisher-id">ARYA</journal-id><journal-title-group><journal-title>ARYA Atherosclerosis</journal-title></journal-title-group><issn pub-type="ppub">1735-3955</issn><issn pub-type="epub">2251-6638</issn><publisher><publisher-name>Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23696766</article-id><article-id pub-id-type="pmc">3653258</article-id><article-id pub-id-type="publisher-id">ARYA-09-98</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of Citrus sinensis juice on blood pressure</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Asgary</surname><given-names>Sedigheh</given-names></name><xref ref-type="aff" rid="af1-ARYA-09-98">1</xref></contrib><contrib contrib-type="author"><name><surname>Keshvari</surname><given-names>Mahtab</given-names></name><xref ref-type="aff" rid="af2-ARYA-09-98">2</xref><xref rid="c1-ARYA-09-98" ref-type="corresp"></xref></contrib></contrib-group><aff id="af1-ARYA-09-98"><label>1</label>Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, And Physiology Research Center, Isfahan</aff><aff id="af2-ARYA-09-98"><label>2</label>Falavarjan Branch, Islamic Azad University, Falavarjan, And Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="c1-ARYA-09-98">Correspondence to:Mahtab Keshvari, Email: <email xlink:href="mahtabkeshvari87@yahoo.com">mahtabkeshvari87@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2013</year></pub-date><volume>9</volume><issue>1</issue><fpage>98</fpage><lpage>101</lpage><history><date date-type="received"><day>21</day><month>5</month><year>2012</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2012</year></date></history><permissions><copyright-statement>Â© 2013 Isfahan Cardiovascular Research Center &amp; Isfahan University of Medical Sciences</copyright-statement><copyright-year>2013</copyright-year><license xlink:href="http://creativecommons.org/licenses/by-nc/3.0/" license-type="open-access"><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2986" xml_f="2996" txt_i="11" txt_f="21">BACKGROUND</offsets></title><p><offsets xml_i="3007" xml_f="3287" txt_i="22" txt_f="302">Citrus sinensis juice (CSJ) is a rich source of dietary flavonoids which reduce the risk of adverse cardiovascular events. This study aimed to examine the effects of four-week intake of natural and commercial orange (Citrus sinensis) juice on blood pressure in healthy volunteers.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3318" xml_f="3325" txt_i="304" txt_f="311">METHODS</offsets></title><p><offsets xml_i="3336" xml_f="3859" txt_i="312" txt_f="835">In this single-blind randomized crossover study, 22 healthy subjects (age: 18-59 years old) were included and randomly divided into two groups of 11. Group A consumed commercial CSJ during the first four-week period. After a two-week washout period, they consumed natural CSJ for another four weeks. The procedure was reversed in group B. The participants were asked to drink 500 ml/day of either natural or commercial CSJ twice a day with breakfast and dinner. The effects of orange juice on blood pressure were evaluated.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3890" xml_f="3897" txt_i="837" txt_f="844">RESULTS</offsets></title><p><offsets xml_i="3908" xml_f="4177" txt_i="845" txt_f="1114">After drinking commercial CSJ, diastolic and systolic blood pressure were significantly decreased (5.13%; P = 0.03 and -5.91%; P = 0.003, respectively). However, consumption of natural CSJ did not have significant effects on either diastolic or systolic blood pressure.</offsets></p></sec><sec id="st4"><title><offsets xml_i="4208" xml_f="4218" txt_i="1116" txt_f="1126">CONCLUSION</offsets></title><p><offsets xml_i="4229" xml_f="4514" txt_i="1127" txt_f="1412">Commercial CSJ significantly decreased blood pressure. Higher flavonoid, pectin, and essential oils content of concentrated products compared to natural juice might have been responsible for this finding. Nevertheless, further studies to focus on dose-response effects are recommended.</offsets></p></sec></abstract><kwd-group><kwd>Citrus Sinensis Juice</kwd><kwd>Hypertension</kwd><kwd>Blood Pressure</kwd></kwd-group></article-meta></front><body><sec><title><offsets xml_i="4679" xml_f="4691" txt_i="1421" txt_f="1433">Introduction</offsets></title><p><offsets xml_i="4702" xml_f="4946" txt_i="1434" txt_f="1678">Hypertension is a major risk factor for cardiovascular diseases (CVD) whose global prevalence is predicted to be as high as 30% by 2025. Approximately 25% (6.6 million) 25-64 year-old have hypertension and 46% (12 million) have prehypertension.</offsets><xref ref-type="bibr" rid="b1-ARYA-09-98"><offsets xml_i="4988" xml_f="4989" txt_i="1678" txt_f="1679">1</offsets></xref><offsets xml_i="4996" xml_f="4997" txt_i="1679" txt_f="1680">,</offsets><xref ref-type="bibr" rid="b2-ARYA-09-98"><offsets xml_i="5039" xml_f="5040" txt_i="1680" txt_f="1681">2</offsets></xref><offsets xml_i="5047" xml_f="5383" txt_i="1681" txt_f="2017"> A growing number of epidemiological studies have consistently shown the protective effect of polyphenol-rich foods (fruit, tea, wine, cocoa or chocolate, and special citrus fruits) against some intermediate risk factors for CVD including high low-density lipoprotein (LDL) cholesterol, high blood pressure, and endothelial dysfunction.</offsets><xref ref-type="bibr" rid="b3-ARYA-09-98"><offsets xml_i="5425" xml_f="5426" txt_i="2017" txt_f="2018">3</offsets></xref><offsets xml_i="5433" xml_f="5434" txt_i="2018" txt_f="2019">-</offsets><xref ref-type="bibr" rid="b5-ARYA-09-98"><offsets xml_i="5476" xml_f="5477" txt_i="2019" txt_f="2020">5</offsets></xref><offsets xml_i="5484" xml_f="5493" txt_i="2020" txt_f="2029"> Orange (</offsets><italic><offsets xml_i="5501" xml_f="5516" txt_i="2029" txt_f="2044">Citrus sinensis</offsets></italic><offsets xml_i="5525" xml_f="5748" txt_i="2044" txt_f="2267">) juice is also considered a good source of essential nutrients such as vitamin C, folate, and potassium. Vitamin C has recently been found to protect endothelial cells and LDL from intra- and extracellular oxidative stress</offsets><xref ref-type="bibr" rid="b6-ARYA-09-98"><offsets xml_i="5790" xml_f="5791" txt_i="2267" txt_f="2268">6</offsets></xref><offsets xml_i="5798" xml_f="5841" txt_i="2268" txt_f="2311"> and to reduce the risk of atherosclerosis.</offsets><xref ref-type="bibr" rid="b7-ARYA-09-98"><offsets xml_i="5883" xml_f="5884" txt_i="2311" txt_f="2312">7</offsets></xref><offsets xml_i="5891" xml_f="6040" txt_i="2312" txt_f="2461"> In addition, folic acid can lower plasma homocysteine concentrations and to revert endothelial dysfunction in patients with cardiovascular diseases.</offsets><xref ref-type="bibr" rid="b8-ARYA-09-98"><offsets xml_i="6082" xml_f="6083" txt_i="2461" txt_f="2462">8</offsets></xref><offsets xml_i="6090" xml_f="6160" txt_i="2462" txt_f="2532"> Potassium, on the other hand, may contribute to lower blood pressure.</offsets><xref ref-type="bibr" rid="b6-ARYA-09-98"><offsets xml_i="6202" xml_f="6203" txt_i="2532" txt_f="2533">6</offsets></xref><offsets xml_i="6210" xml_f="6211" txt_i="2533" txt_f="2534">-</offsets><xref ref-type="bibr" rid="b9-ARYA-09-98"><offsets xml_i="6253" xml_f="6254" txt_i="2534" txt_f="2535">9</offsets></xref><offsets xml_i="6261" xml_f="6511" txt_i="2535" txt_f="2785"> Four-week consumption of orange juice in healthy middle-aged, normal-weight men has been suggested to reduce diastolic blood pressure (DBP). Since DBP is an indicator of peripheral vessel resistance, orange juice can have particular health benefits.</offsets><xref ref-type="bibr" rid="b10-ARYA-09-98"><offsets xml_i="6554" xml_f="6556" txt_i="2785" txt_f="2787">10</offsets></xref></p><p><offsets xml_i="6570" xml_f="6879" txt_i="2788" txt_f="3097">Citrus sinensis juice (CSJ) consumption has become a worldwide dietary habit. As a result, the consumption of frozen concentrated juice has also increased steadily over years. Not surprisingly, the market share of this product is now much greater than that of natural fruit, especially in developed countries.</offsets><xref ref-type="bibr" rid="b11-ARYA-09-98"><offsets xml_i="6922" xml_f="6924" txt_i="3097" txt_f="3099">11</offsets></xref><offsets xml_i="6931" xml_f="7161" txt_i="3099" txt_f="3329"> Furthermore, it was hypothesized that natural and commercial orange juice consumption have different effects on blood pressure in healthy volunteers. This study aimed to examine the effects of four-week intake of natural orange (</offsets><italic><offsets xml_i="7169" xml_f="7184" txt_i="3329" txt_f="3344">Citrus sinensis</offsets></italic><offsets xml_i="7193" xml_f="7260" txt_i="3344" txt_f="3411">) juice and commercial CSJ on blood pressure in healthy volunteers.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="7311" xml_f="7332" txt_i="3413" txt_f="3434">Materials and Methods</offsets></title><p><offsets xml_i="7343" xml_f="7344" txt_i="3435" txt_f="3436">
</offsets><bold><offsets xml_i="7350" xml_f="7358" txt_i="3436" txt_f="3444">Subjects</offsets></bold><offsets xml_i="7365" xml_f="7366" txt_i="3444" txt_f="3445">
</offsets></p><p><offsets xml_i="7373" xml_f="7738" txt_i="3446" txt_f="3811">This single-blind, randomized, crossover study was conducted on 22 healthy volunteers (age: 18-59 years old) with no evidence of chronic, metabolic, and endocrine diseases. The exclusion criteria were using medications, antioxidants, or vitamin supplements, intense physical activity (five hours a week), smoking, and vegetarian or other restrictive dietary habits.</offsets></p><p><offsets xml_i="7745" xml_f="8627" txt_i="3812" txt_f="4694">Using a protocol approved by the ethics committee of Isfahan Cardiovascular Research Center (Isfahan, Iran), this study mainly aimed at comparing the effects of four-week consumption of natural and commercial orange juice on blood pressure in healthy volunteers. The subjects were hence allocated to two groups of 11 using computer-generated random numbers. Group A received commercial orange juice for four weeks, had a two-week washout period, and consumed natural orange juice for another four weeks. The reverse order was used in group B. Commercial orange juice without preservatives, extra vitamin C, or other additives was purchased. Natural fruits were also bought at the fruit market, crushed, and then squeezed. Both types of juice were stored in one-liter bottles at 20Â°C. The subjects were asked to drink 500 ml/day of orange juice twice a day with breakfast and dinner.</offsets></p><p><offsets xml_i="8634" xml_f="8977" txt_i="4695" txt_f="5038">In order to measure blood pressure, the participants made four visits to the clinical research unit, i.e. before and 30 days after each experimental period. All measurements were performed in the morning and after a 20-minute rest using a stethoscope and a sphygmomanometer (Accutorr 1A, Datascope, Japan) and according to a standard protocol.</offsets><xref ref-type="bibr" rid="b12-ARYA-09-98"><offsets xml_i="9020" xml_f="9022" txt_i="5038" txt_f="5040">12</offsets></xref></p><p><offsets xml_i="9036" xml_f="9874" txt_i="5041" txt_f="5879">The collected data was reported as means Â± standard deviation (SD). A paired t-test was performed to analyze data obtained by the crossover design before and after juice supplementation and to determine possible significant differences in blood pressure between time points. A paired t-test between baseline values (before either natural or commercial orange juice supplementation) was used to establish the correct performance of the washout. A paired t-test was also used to compare the mean values obtained before and after the experiment period. Data was compared by repeated-measures analysis of variance with Dunnettâs post-test for nonparametric data. In all cases, P values less than 0.05 were considered statistically significant. All statistical analyses were performed using SPSS for Windows 15.0 (SPSS Inc., Chicago, IL, USA).</offsets></p></sec><sec sec-type="result"><title><offsets xml_i="9914" xml_f="9921" txt_i="5881" txt_f="5888">Results</offsets></title><p><offsets xml_i="9932" xml_f="10277" txt_i="5889" txt_f="6234">Overall, 22 subjects were included. The mean age of the participants was 34.36 Â± 11.54 years old in group A and 35.91 Â± 12.80 years old in group B (P = 0.769). The mean SBP in groups A and B was 112.00 Â± 8.50 and 110.91 Â± 7.01 mmHg, respectively (P = 0.555). The mean DBP was 78.0 Â± 11.35 mmHg in group A and 72.73 Â± 4.67 in group B (P = 0.130).</offsets></p><p><offsets xml_i="10284" xml_f="10598" txt_i="6235" txt_f="6549">Blood pressure was measured at the beginning and at the end of each experimental period. There was a statistically significant difference in DBP between the two groups the first and second experimental periods. However, within group comparisons did not reveal statistically significant differences in DBP and SBP (</offsets><xref ref-type="table" rid="t1-ARYA-09-98"><offsets xml_i="10641" xml_f="10648" txt_i="6549" txt_f="6556">Table 1</offsets></xref><offsets xml_i="10655" xml_f="10657" txt_i="6556" txt_f="6558">).</offsets></p><p><offsets xml_i="10664" xml_f="10912" txt_i="6559" txt_f="6807">In addition, DBP and SBP had significant reductions after commercial orange juice consumption (-5.13% and -5.91% respectively). Nevertheless, commercial orange juice resulted in a significantly lower DBP reduction compared to natural orange juice (</offsets><xref ref-type="table" rid="t2-ARYA-09-98"><offsets xml_i="10955" xml_f="10962" txt_i="6807" txt_f="6814">Table 2</offsets></xref><offsets xml_i="10969" xml_f="10971" txt_i="6814" txt_f="6816">).</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="11015" xml_f="11025" txt_i="6818" txt_f="6828">Discussion</offsets></title><p><offsets xml_i="11036" xml_f="11212" txt_i="6829" txt_f="7005">The main finding of this study is that four-week consumption of commercial CSJ significantly decreased DBP and SBP in healthy subjects. Morand et al. reported similar findings.</offsets><xref ref-type="bibr" rid="b13-ARYA-09-98"><offsets xml_i="11255" xml_f="11257" txt_i="7005" txt_f="7007">13</offsets></xref><offsets xml_i="11264" xml_f="11374" txt_i="7007" txt_f="7117"> Hara showed that four-week consumption of orange juice reduced DBP in healthy middle-aged, normal-weight men.</offsets><xref ref-type="bibr" rid="b14-ARYA-09-98"><offsets xml_i="11417" xml_f="11419" txt_i="7117" txt_f="7119">14</offsets></xref><offsets xml_i="11426" xml_f="11581" txt_i="7119" txt_f="7274"> Moreover, studies have shown consumption of flavanone-rich fruit juice to have a significant beneficial effect on blood pressure in hypertensive subjects.</offsets><xref ref-type="bibr" rid="b10-ARYA-09-98"><offsets xml_i="11624" xml_f="11626" txt_i="7274" txt_f="7276">10</offsets></xref><offsets xml_i="11633" xml_f="11634" txt_i="7276" txt_f="7277">,</offsets><xref ref-type="bibr" rid="b14-ARYA-09-98"><offsets xml_i="11677" xml_f="11679" txt_i="7277" txt_f="7279">14</offsets></xref><offsets xml_i="11686" xml_f="11853" txt_i="7279" txt_f="7446"> Focus on flavanones is particularly relevant considering their high content in citrus and high consumption of citrus fruits, and particularly orange juice, worldwide.</offsets><xref ref-type="bibr" rid="b15-ARYA-09-98"><offsets xml_i="11896" xml_f="11898" txt_i="7446" txt_f="7448">15</offsets></xref><offsets xml_i="11905" xml_f="12047" txt_i="7448" txt_f="7590"> Concentrated citrus products have a greater flavonoid (polymethoxylated flavones, hesperitin and naringin) content compared to natural juice.</offsets><xref ref-type="bibr" rid="b16-ARYA-09-98"><offsets xml_i="12090" xml_f="12092" txt_i="7590" txt_f="7592">16</offsets></xref><offsets xml_i="12099" xml_f="12294" txt_i="7592" txt_f="7787"> This is due to the grinding process which uses the entire fruit to produce the juice. Pectin and essential oils contained in the peel are also found in greater amounts in the concentrated juice.</offsets><xref ref-type="bibr" rid="b16-ARYA-09-98"><offsets xml_i="12337" xml_f="12339" txt_i="7787" txt_f="7789">16</offsets></xref><offsets xml_i="12346" xml_f="12596" txt_i="7789" txt_f="8039"> Naringin and hesperidin are mainly present in grapefruits and oranges. They have been reported to possess antioxidant, antihypertensive, and hypocholesterolemic effects and to offer some kind of protection against mutagenesis and lipid peroxidation.</offsets><xref ref-type="bibr" rid="b17-ARYA-09-98"><offsets xml_i="12639" xml_f="12641" txt_i="8039" txt_f="8041">17</offsets></xref><offsets xml_i="12648" xml_f="12649" txt_i="8041" txt_f="8042">,</offsets><xref ref-type="bibr" rid="b18-ARYA-09-98"><offsets xml_i="12692" xml_f="12694" txt_i="8042" txt_f="8044">18</offsets></xref><offsets xml_i="12701" xml_f="12981" txt_i="8044" txt_f="8324"> In healthy, middle-aged, moderately overweight men, regular postprandial consumption of Citrus sinesis juice (CSJ) has been found to decrease DBP and increase endothelium-dependent microvascular reactivity. Hesperidin was suggested to cause the beneficial effect of orange juice.</offsets><xref ref-type="bibr" rid="b13-ARYA-09-98"><offsets xml_i="13024" xml_f="13026" txt_i="8324" txt_f="8326">13</offsets></xref><offsets xml_i="13033" xml_f="13146" txt_i="8326" txt_f="8439"> Law et al. showed that a 3-4 mmHg reduction in DBP would reduce the incidence of coronary artery disease by 20%.</offsets><xref ref-type="bibr" rid="b19-ARYA-09-98"><offsets xml_i="13189" xml_f="13191" txt_i="8439" txt_f="8441">19</offsets></xref></p><p><offsets xml_i="13205" xml_f="13544" txt_i="8442" txt_f="8781">The possible mechanisms by which these flavonoid-rich foods lowered blood pressure may involve a chronic increase in the production of nitrogen oxide (NO) by vascular endothelium. Other mechanisms such as an inhibitory effect on angiotensin-converting enzyme could also be responsible for the blood pressure-lowering effects of flavanones.</offsets><xref ref-type="bibr" rid="b13-ARYA-09-98"><offsets xml_i="13587" xml_f="13589" txt_i="8781" txt_f="8783">13</offsets></xref><offsets xml_i="13596" xml_f="13597" txt_i="8783" txt_f="8784">,</offsets><xref ref-type="bibr" rid="b20-ARYA-09-98"><offsets xml_i="13640" xml_f="13642" txt_i="8784" txt_f="8786">20</offsets></xref><offsets xml_i="13649" xml_f="13650" txt_i="8786" txt_f="8787">,</offsets><xref ref-type="bibr" rid="b21-ARYA-09-98"><offsets xml_i="13693" xml_f="13695" txt_i="8787" txt_f="8789">21</offsets></xref><offsets xml_i="13702" xml_f="13987" txt_i="8789" txt_f="9074"> Endothelium dysfunction causes the endothelium to become permeable to plasma components such as LDL which are deposited in the subendothelial space. Consequently, endothelial dysfunction can be considered as the first step in atherogenesis and development of arteriosclerotic lesions.</offsets><xref ref-type="bibr" rid="b22-ARYA-09-98"><offsets xml_i="14030" xml_f="14032" txt_i="9074" txt_f="9076">22</offsets></xref><offsets xml_i="14039" xml_f="14040" txt_i="9076" txt_f="9077">-</offsets><xref ref-type="bibr" rid="b24-ARYA-09-98"><offsets xml_i="14083" xml_f="14085" txt_i="9077" txt_f="9079">24</offsets></xref></p><p><offsets xml_i="14099" xml_f="14208" txt_i="9080" txt_f="9189">In general, association between flavonoid intake and blood pressure is a theory which requires more research.</offsets></p><sec><title><offsets xml_i="14224" xml_f="14234" txt_i="9190" txt_f="9200">Conclusion</offsets></title><p><offsets xml_i="14245" xml_f="14536" txt_i="9201" txt_f="9492">Commercial orange juice has a significant effect on blood pressure. As concentrated products have greater contents of flavonoids, pectin, and essential oils compared to natural juice, they are more effective on blood pressure. Future studies to examine dose-response effects are recommended.</offsets></p></sec></sec></body><back><fn-group><fn><p>
<bold>Conflicts of Interest</bold>
</p><p>Authors have no conflict of interests.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-ARYA-09-98"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kapil</surname><given-names>V</given-names></name><name><surname>Milsom</surname><given-names>AB</given-names></name><name><surname>Okorie</surname><given-names>M</given-names></name><name><surname>Maleki-Toyserkani</surname><given-names>S</given-names></name><name><surname>Akram</surname><given-names>F</given-names></name><name><surname>Rehman</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title> Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO.</article-title>
<source>Hypertension</source>
<year>2010</year>
<volume>56</volume>
<issue>2</issue>
<fpage>274</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">20585108</pub-id></element-citation></ref><ref id="b2-ARYA-09-98"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esteghamati</surname><given-names>A</given-names></name><name><surname>Abbasi</surname><given-names>M</given-names></name><name><surname>Alikhani</surname><given-names>S</given-names></name><name><surname>Gouya</surname><given-names>MM</given-names></name><name><surname>Delavari</surname><given-names>A</given-names></name><name><surname>Shishehbor</surname><given-names>MH</given-names></name><etal></etal></person-group>
<article-title> Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran.</article-title>
<source>Am J Hypertens</source>
<year>2008</year>
<volume>21</volume>
<issue>6</issue>
<fpage>620</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">18451810</pub-id></element-citation></ref><ref id="b3-ARYA-09-98"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hooper</surname><given-names>L</given-names></name><name><surname>Kroon</surname><given-names>PA</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Cohn</surname><given-names>JS</given-names></name><name><surname>Harvey</surname><given-names>I</given-names></name><name><surname>Le Cornu</surname><given-names>KA</given-names></name><etal></etal></person-group>
<article-title> Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials.</article-title>
<source>Am J Clin Nutr</source>
<year>2008</year>
<volume>88</volume>
<issue>1</issue>
<fpage>38</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">18614722</pub-id></element-citation></ref><ref id="b4-ARYA-09-98"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnsen</surname><given-names>SP</given-names></name><name><surname>Overvad</surname><given-names>K</given-names></name><name><surname>Stripp</surname><given-names>C</given-names></name><name><surname>Tjonneland</surname><given-names>A</given-names></name><name><surname>Husted</surname><given-names>SE</given-names></name><name><surname>Sorensen</surname><given-names>HT</given-names></name></person-group>
<article-title> Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women.</article-title>
<source>Am J Clin Nutr</source>
<year>2003</year>
<volume>78</volume>
<issue>1</issue>
<fpage>57</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="pmid">12816771</pub-id></element-citation></ref><ref id="b5-ARYA-09-98"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dauchet</surname><given-names>L</given-names></name><name><surname>Ferrieres</surname><given-names>J</given-names></name><name><surname>Arveiler</surname><given-names>D</given-names></name><name><surname>Yarnell</surname><given-names>JW</given-names></name><name><surname>Gey</surname><given-names>F</given-names></name><name><surname>Ducimetiere</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title> Frequency of fruit and vegetable consumption and coronary heart disease in France and Northern Ireland: the PRIME study.</article-title>
<source>Br J Nutr</source>
<year>2004</year>
<volume>92</volume>
<issue>6</issue>
<fpage>963</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">15613259</pub-id></element-citation></ref><ref id="b6-ARYA-09-98"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sabharwal</surname><given-names>AK</given-names></name><name><surname>May</surname><given-names>JM</given-names></name></person-group>
<article-title> alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells.</article-title>
<source>Mol Cell Biochem</source>
<year>2008</year>
<volume>309</volume>
<issue>1-2</issue>
<fpage>125</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">18026819</pub-id></element-citation></ref><ref id="b7-ARYA-09-98"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boekholdt</surname><given-names>SM</given-names></name><name><surname>Meuwese</surname><given-names>MC</given-names></name><name><surname>Day</surname><given-names>NE</given-names></name><name><surname>Luben</surname><given-names>R</given-names></name><name><surname>Welch</surname><given-names>A</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><etal></etal></person-group>
<article-title> Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study.</article-title>
<source>Br J Nutr</source>
<year>2006</year>
<volume>96</volume>
<issue>3</issue>
<fpage>516</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">16925857</pub-id></element-citation></ref><ref id="b8-ARYA-09-98"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moat</surname><given-names>SJ</given-names></name><name><surname>Lang</surname><given-names>D</given-names></name><name><surname>McDowell</surname><given-names>IF</given-names></name><name><surname>Clarke</surname><given-names>ZL</given-names></name><name><surname>Madhavan</surname><given-names>AK</given-names></name><name><surname>Lewis</surname><given-names>MJ</given-names></name><etal></etal></person-group>
<article-title> Folate, homocysteine, endothelial function and cardiovascular disease.</article-title>
<source>J Nutr Biochem</source>
<year>2004</year>
<volume>15</volume>
<issue>2</issue>
<fpage>64</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">14972346</pub-id></element-citation></ref><ref id="b9-ARYA-09-98"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Havas</surname><given-names>S</given-names></name><name><surname>Kotchen</surname><given-names>TA</given-names></name><etal></etal></person-group>
<article-title> Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program.</article-title>
<source>JAMA</source>
<year>2002</year>
<volume>288</volume>
<issue>15</issue>
<fpage>1882</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">12377087</pub-id></element-citation></ref><ref id="b10-ARYA-09-98"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reshef</surname><given-names>N</given-names></name><name><surname>Hayari</surname><given-names>Y</given-names></name><name><surname>Goren</surname><given-names>C</given-names></name><name><surname>Boaz</surname><given-names>M</given-names></name><name><surname>Madar</surname><given-names>Z</given-names></name><name><surname>Knobler</surname><given-names>H</given-names></name></person-group>
<article-title> Antihypertensive effect of sweetie fruit in patients with stage I hypertension.</article-title>
<source>Am J Hypertens</source>
<year>2005</year>
<volume>18</volume>
<issue>10</issue>
<fpage>1360</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">16202862</pub-id></element-citation></ref><ref id="b11-ARYA-09-98"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Devaraj</surname><given-names>S</given-names></name><name><surname>Jialal</surname><given-names>I</given-names></name><name><surname>Rockwood</surname><given-names>J</given-names></name><name><surname>Zak</surname><given-names>D</given-names></name></person-group>
<article-title> Effect of orange juice and beverage with phytosterols on cytokines and PAI-1 activity.</article-title>
<source>Clin Nutr</source>
<year>2011</year>
<volume>30</volume>
<issue>5</issue>
<fpage>668</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">21477901</pub-id></element-citation></ref><ref id="b12-ARYA-09-98"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>JS</given-names></name><name><surname>Brown</surname><given-names>SM</given-names></name><name><surname>Conlin</surname><given-names>PR</given-names></name></person-group>
<article-title> Videos in clinical medicine. Blood-pressure measurement.</article-title>
<source>N Engl J Med</source>
<year>2009</year>
<volume>360</volume>
<issue>5</issue>
<fpage>e6</fpage>
<pub-id pub-id-type="pmid">19179309</pub-id></element-citation></ref><ref id="b13-ARYA-09-98"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morand</surname><given-names>C</given-names></name><name><surname>Dubray</surname><given-names>C</given-names></name><name><surname>Milenkovic</surname><given-names>D</given-names></name><name><surname>Lioger</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name><name><surname>Scalbert</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title> Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers.</article-title>
<source>Am J Clin Nutr</source>
<year>2011</year>
<volume>93</volume>
<issue>1</issue>
<fpage>73</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">21068346</pub-id></element-citation></ref><ref id="b14-ARYA-09-98"><label>14</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Hara</surname><given-names>Y</given-names></name></person-group>
<article-title> Prophylactic functions of tea polyphenols.</article-title>
<person-group person-group-type="editor"><name><surname>Ho</surname><given-names>CT</given-names></name></person-group>
<source>Food phytochemicals for cancer prevention II: teas, spices, and herbs.</source>
<publisher-loc>Washington, DC</publisher-loc>
<publisher-name>American Chemical Soc</publisher-name>
<year>1994</year>
</element-citation></ref><ref id="b15-ARYA-09-98"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neveu</surname><given-names>V</given-names></name><name><surname>Perez-Jimenez</surname><given-names>J</given-names></name><name><surname>Vos</surname><given-names>F</given-names></name><name><surname>Crespy</surname><given-names>V</given-names></name><name><surname>du</surname><given-names>CL</given-names></name><name><surname>Mennen</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title> Phenol-Explorer: an online comprehensive database on polyphenol contents in foods.</article-title>
<source>Database (Oxford)</source>
<year>2010</year>
<volume>2010</volume>
<fpage>bap024</fpage>
<pub-id pub-id-type="pmid">20428313</pub-id></element-citation></ref><ref id="b16-ARYA-09-98"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cesar</surname><given-names>TB</given-names></name><name><surname>Aptekmann</surname><given-names>NP</given-names></name><name><surname>Araujo</surname><given-names>MP</given-names></name><name><surname>Vinagre</surname><given-names>CC</given-names></name><name><surname>Maranhao</surname><given-names>RC</given-names></name></person-group>
<article-title> Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects.</article-title>
<source>Nutr Res</source>
<year>2010</year>
<volume>30</volume>
<issue>10</issue>
<fpage>689</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">21056284</pub-id></element-citation></ref><ref id="b17-ARYA-09-98"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aranganathan</surname><given-names>S</given-names></name><name><surname>Panneer</surname><given-names>SJ</given-names></name><name><surname>Nalini</surname><given-names>N</given-names></name></person-group>
<article-title> Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis.</article-title>
<source>Invest New Drugs</source>
<year>2009</year>
<volume>27</volume>
<issue>3</issue>
<fpage>203</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">18648748</pub-id></element-citation></ref><ref id="b18-ARYA-09-98"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jin</surname><given-names>YR</given-names></name><name><surname>Im</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>ES</given-names></name><name><surname>Cho</surname><given-names>MR</given-names></name><name><surname>Han</surname><given-names>XH</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><etal></etal></person-group>
<article-title> Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.</article-title>
<source>J Cardiovasc Pharmacol</source>
<year>2008</year>
<volume>51</volume>
<issue>1</issue>
<fpage>45</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">18209568</pub-id></element-citation></ref><ref id="b19-ARYA-09-98"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Law</surname><given-names>MR</given-names></name><name><surname>Morris</surname><given-names>JK</given-names></name><name><surname>Wald</surname><given-names>NJ</given-names></name></person-group>
<article-title> Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.</article-title>
<source>BMJ</source>
<year>2009</year>
<volume>338</volume>
<fpage>b1665</fpage>
<pub-id pub-id-type="pmid">19454737</pub-id></element-citation></ref><ref id="b20-ARYA-09-98"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heller</surname><given-names>R</given-names></name><name><surname>Unbehaun</surname><given-names>A</given-names></name><name><surname>Schellenberg</surname><given-names>B</given-names></name><name><surname>Mayer</surname><given-names>B</given-names></name><name><surname>Werner-Felmayer</surname><given-names>G</given-names></name><name><surname>Werner</surname><given-names>ER</given-names></name></person-group>
<article-title> L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin.</article-title>
<source>J Biol Chem</source>
<year>2001</year>
<volume>276</volume>
<issue>1</issue>
<fpage>40</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">11022034</pub-id></element-citation></ref><ref id="b21-ARYA-09-98"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Actis-Goretta</surname><given-names>L</given-names></name><name><surname>Ottaviani</surname><given-names>JI</given-names></name><name><surname>Fraga</surname><given-names>CG</given-names></name></person-group>
<article-title> Inhibition of angiotensin converting enzyme activity by flavanol-rich foods.</article-title>
<source>J Agric Food Chem</source>
<year>2006</year>
<volume>54</volume>
<issue>1</issue>
<fpage>229</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">16390204</pub-id></element-citation></ref><ref id="b22-ARYA-09-98"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marx</surname><given-names>N</given-names></name><name><surname>Grant</surname><given-names>PJ</given-names></name></person-group>
<article-title> Endothelial dysfunction and cardiovascular disease-the lull before the storm.</article-title>
<source>Diab Vasc Dis Res</source>
<year>2007</year>
<volume>4</volume>
<issue>2</issue>
<fpage>82</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">17654440</pub-id></element-citation></ref><ref id="b23-ARYA-09-98"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bonetti</surname><given-names>PO</given-names></name><name><surname>Lerman</surname><given-names>LO</given-names></name><name><surname>Lerman</surname><given-names>A</given-names></name></person-group>
<article-title> Endothelial dysfunction: a marker of atherosclerotic risk.</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2003</year>
<volume>23</volume>
<issue>2</issue>
<fpage>168</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">12588755</pub-id></element-citation></ref><ref id="b24-ARYA-09-98"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weissberg</surname><given-names>P</given-names></name></person-group>
<article-title> Mechanisms modifying atherosclerotic disease - from lipids to vascular biology.</article-title>
<source>Atherosclerosis</source>
<year>1999</year>
<volume>147</volume>
<issue>Suppl 1</issue>
<fpage>S3</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">10575056</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-ARYA-09-98" position="float"><label>Table 1</label><caption><p>Comparison of the two groups before and after each experimental period</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">T1</th><th align="center" rowspan="1" colspan="1">T2</th><th align="center" rowspan="1" colspan="1">P</th><th align="center" rowspan="1" colspan="1">T3</th><th align="center" rowspan="1" colspan="1">T4</th><th align="center" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">
Systolic blood pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">
Group A</td><td align="center" rowspan="1" colspan="1">
112.00 Â± 8.50</td><td align="center" rowspan="1" colspan="1">
108.00 Â± 7.89</td><td align="center" rowspan="1" colspan="1">
0.020</td><td align="center" rowspan="1" colspan="1">
112.55 Â± 8.20</td><td align="center" rowspan="1" colspan="1">
110.91 Â± 11.36</td><td align="center" rowspan="1" colspan="1">
0.271</td></tr><tr><td align="center" rowspan="1" colspan="1">
Group B</td><td align="center" rowspan="1" colspan="1">
110.91 Â± 7.01</td><td align="center" rowspan="1" colspan="1">
106.36 Â± 6.74</td><td align="center" rowspan="1" colspan="1">
0.129</td><td align="center" rowspan="1" colspan="1">
110.91 Â± 7.01</td><td align="center" rowspan="1" colspan="1">
104.55 Â± 8.20</td><td align="center" rowspan="1" colspan="1">
0.053</td></tr><tr><td align="center" rowspan="1" colspan="1">
P</td><td align="center" rowspan="1" colspan="1">
0.555</td><td align="center" rowspan="1" colspan="1">
0.917</td><td align="center" rowspan="1" colspan="1">
0.860</td><td align="center" rowspan="1" colspan="1">
0.630</td><td align="center" rowspan="1" colspan="1">
0.119</td><td align="center" rowspan="1" colspan="1">
0.840</td></tr><tr><td rowspan="3" colspan="1">
Diastolic blood pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">
Group A</td><td align="center" rowspan="1" colspan="1">
78.00 Â± 11.35</td><td align="center" rowspan="1" colspan="1">
72.00 Â± 7.89</td><td align="center" rowspan="1" colspan="1">
0.050</td><td align="center" rowspan="1" colspan="1">
75.45 Â± 11.28</td><td align="center" rowspan="1" colspan="1">
76.36 Â± 10.27</td><td align="center" rowspan="1" colspan="1">
0.792</td></tr><tr><td align="center" rowspan="1" colspan="1">
Group B</td><td align="center" rowspan="1" colspan="1">
72.73 Â± 4.67</td><td align="center" rowspan="1" colspan="1">
70.91 Â± 7.01</td><td align="center" rowspan="1" colspan="1">
0.317</td><td align="center" rowspan="1" colspan="1">
72.91 Â± 5.39</td><td align="center" rowspan="1" colspan="1">
69.09 Â± 5.39</td><td align="center" rowspan="1" colspan="1">
0.050</td></tr><tr><td align="center" rowspan="1" colspan="1">
P</td><td align="center" rowspan="1" colspan="1">
0.130</td><td align="center" rowspan="1" colspan="1">
0.400</td><td align="center" rowspan="1" colspan="1">
0.204</td><td align="center" rowspan="1" colspan="1">
0.011</td><td align="center" rowspan="1" colspan="1">
0.146</td><td align="center" rowspan="1" colspan="1">
0.490</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ARYA-09-98"><p>Group A consumed commercial Citrus sinensis juice during the first period and natural Citrus sinensis juice during the second. Group B consumed natural Citrus sinensis juice during the first period and commercial Citrus sinensis juice during the second.</p></fn><fn id="tfn2-ARYA-09-98"><p>T1: Before the first period</p></fn><fn id="tfn3-ARYA-09-98"><p>T2: After the first period</p></fn><fn id="tfn4-ARYA-09-98"><p>T3: Before the second period</p></fn><fn id="tfn5-ARYA-09-98"><p>T4: After the second period</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ARYA-09-98" position="float"><label>Table 2</label><caption><p>Changes in systolic and diastolic blood pressure (SBP and DBP) after the intervention compared to baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">Commercial orange juiceusers (n = 22)</th><th align="center" rowspan="1" colspan="1">Natural orange juiceusers (n = 22)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
SBP (mmHg)</td><td align="center" rowspan="1" colspan="1">
-5.91%</td><td align="center" rowspan="1" colspan="1">
-3.63%</td></tr><tr><td rowspan="1" colspan="1">
DBP (mmHg)</td><td align="center" rowspan="1" colspan="1">
-5.13%</td><td align="center" rowspan="1" colspan="1">
-0.61%</td></tr></tbody></table><table-wrap-foot><fn id="tfn6-ARYA-09-98"><p>SBP: Systolic blood pressure; DBO: diastolic blood pressure</p></fn></table-wrap-foot></table-wrap></floats-group></article>